Mice with a genetically engineered deficiency for either IL-4 or IFN-g
amma R1 (single mutants), and IL-4/IFN-gamma R1 (double mutants) on th
e Balb/c and 129Sv background were used to study the course of infecti
on with Leishmania major. In contrast to genetically resistant 129Sv w
ild-type mice, IL-4/IFN-gamma R1 double mutant mice developed fatal di
sease with parasite dissemination to visceral organs similar to mice l
acking IFN-gamma R1 only. Balb/c mice, which are exquisitely susceptib
le to L. major, were rendered resistant to infection by disruption of
the IL-4 gene. As compared to homozygous IL-4(+/+) mice, heterozygous
IL-4(+/-) animals consistently developed smaller lesions with less ulc
eration and necrosis, indicating the likelihood of gene-dosage effects
. This implicates that the magnitude of the IL-4 response determines t
he severity of disease. CD4(+) T cells of IL-4-deficient mice showed i
mpaired Th2 cell development, as assessed by quantitative RT-PCR of ch
aracteristic cytokines. Development of resistance is not explained by
default Th1 development, because this was observed only at very late s
tages of infection. Moreover, the induction of inflammatory cytokines
(e.g., IL-1 alpha, IL-1 beta, TNF-alpha, IL-12) together with iNOS in
the lesion and draining lymph nodes was not altered in the absence of
IL-4.